Utpal Koppikar - 08 Jun 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Chief Financial Officer
Signature
/s/ David Tucker, Attorney-in-Fact for Utpal Koppikar
Issuer symbol
ATRA
Transactions as of
08 Jun 2021
Net transactions value
-$81,829
Form type
4
Filing time
09 Jun 2021, 16:06:44 UTC
Previous filing
20 May 2021
Next filing
12 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $81,829 -5,820 -3.4% $14.06* 164,948 08 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted Restricted Stock Units.
F2 Includes 1,802 shares issued on May 28, 2021 pursuant to the Issuer's Employee Stock Purchase Plan.